| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/2005 | CN1636554A Process for producing soft gelatin capsule |
| 07/13/2005 | CN1210400C Methods for making proteins contaniing free cysteine residues |
| 07/13/2005 | CN1210398C Superoxide dismutase conjugated substance and preparation method thereof |
| 07/13/2005 | CN1210306C Short-chain neurotoxin of sea serpent and gene for coding it |
| 07/13/2005 | CN1210304C Sequence number 3 bioactive peptide |
| 07/13/2005 | CN1210303C Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases |
| 07/13/2005 | CN1210302C Minor peptide of growth factor receptor KDR of specific combined blood vessel endothelium |
| 07/13/2005 | CN1210301C Bioactive peptide sequential No.18 |
| 07/13/2005 | CN1210300C Bioactive peptide No.29 |
| 07/13/2005 | CN1210299C Sequence No.19 biological active peptide |
| 07/13/2005 | CN1210298C Sequence number 1 bioactive peptide |
| 07/13/2005 | CN1210297C Bioactive peptide sequential No.17 |
| 07/13/2005 | CN1210296C Sequential bioactive peptide No.30 |
| 07/13/2005 | CN1210295C Sequential No.24 bioactive peptide |
| 07/13/2005 | CN1210294C Sequential No.21 bioactive peptide |
| 07/13/2005 | CN1210293C Sequential No.23 bioactive peptide |
| 07/13/2005 | CN1210292C Bioactive peptide sequential No.22 |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/13/2005 | CN1210061C Method of stabilizing protein C or activated protein C and stabilized composition obtained therefrom |
| 07/13/2005 | CN1210060C Medicine for treating phenylketouria, and preparing process and use thereof |
| 07/13/2005 | CN1210059C Fracture healing using PTHrp analogs |
| 07/13/2005 | CN1210058C Stable concentrated insulin preparations for pulmonary delivery |
| 07/13/2005 | CN1210035C Complex external medicine for treating psoriasis |
| 07/13/2005 | CN1210019C II type collagen water soluble dispersion composition, its preparation method and application |
| 07/12/2005 | US6917616 Method and apparatus for reduction and restoration of data elements pertaining to transmitted data packets in a communications network |
| 07/12/2005 | US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 07/12/2005 | US6916917 Chimeric pro-caspases and methods of using same |
| 07/12/2005 | US6916916 Chinese hamster ovaries defective in expression of neuramidase activity for producing glycoproteins with intact carbohydrate chains; antisense agents |
| 07/12/2005 | US6916913 Dorsalin-1 polypeptide and uses thereof |
| 07/12/2005 | US6916910 Cosmetic, drugs; extraction, precipitation, washing |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916905 Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use |
| 07/12/2005 | US6916904 Inhibition of immune complex formation |
| 07/12/2005 | US6916857 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916843 Prevention cell damage due oxygen toxicity by administering epoxyeicosatrienoic acids and/or metabolites, from cytochrome-P450 monooxygenase enzyme ststem |
| 07/12/2005 | US6916793 Treating tumor cells with a selenium prodrug lyase and a selenium-containing prodrug such as selenocysteine, selenohomocysteine, selenomethionine or selenoethionine. |
| 07/12/2005 | US6916790 Treatment of osteoporosis |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916788 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/12/2005 | US6916787 Method for producing hemin proteins using plant cells, resulting proteins and products containing same |
| 07/12/2005 | US6916786 Especially Keratinocyte Growth Factor 12; accelerating wound healing and treating gastrointestinal and respiratory disorders. |
| 07/12/2005 | US6916785 Homogeneous cyclosporin-containing solution |
| 07/12/2005 | US6916784 Acyl derivatives of the echinocandin class of cyclic peptide; parasiticide |
| 07/12/2005 | US6916783 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits |
| 07/12/2005 | US6916782 Gene coding for heliomicine and use thereof |
| 07/12/2005 | US6916654 Universal donor cells |
| 07/12/2005 | US6916653 Ribozymal nucleic acid |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916644 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 07/12/2005 | US6916642 Vertebrate telomerase genes and proteins and uses thereof |
| 07/12/2005 | US6916631 Comprises monoclonal antibody for diagnosis and treatment of skin disorders |
| 07/12/2005 | US6916629 Tissue factor pathway inhibitor-3 |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916624 Antibody for use in the diagnosis and treatment of cancer |
| 07/12/2005 | US6916622 Screening method and a screening system capable of selecting agents capable of interfering with this protein-protein interaction; selection of agents capable of modulating this protein-protein interaction for treatment and control of PV |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916609 Comprises nucleotide sequences coding chaperone protein for diagnosis, prevention and treatment of cancer, immunological and inflammatory diseases |
| 07/12/2005 | US6916607 Gene controlling androgen |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916475 Anti-idiotypic antibody and its use in regulating the composition of T cell lymphocytes |
| 07/12/2005 | US6916471 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds |
| 07/12/2005 | US6916470 Methods for use of mpl ligands with primitive human stem cells |
| 07/12/2005 | US6916303 Photoreduction method for hemoglobin-vesicle |
| 07/12/2005 | CA2349142C Compositions and methods for stimulating gastrointestinal motility |
| 07/12/2005 | CA2303421C Beta-defensins |
| 07/12/2005 | CA2264275C Monoclonal antibody specific to an anti-human fibrin monomer, method for producing the monoclonal antibody, hybridoma, and immunoassay |
| 07/12/2005 | CA2240327C Method for effecting changes in the central nervous system by administration of igf-i or igf-ii |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/12/2005 | CA2230947C Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 07/12/2005 | CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain |
| 07/07/2005 | WO2005061712A1 Muteins of fibroblast growth factor 21 |
| 07/07/2005 | WO2005061701A1 Process for producing polymer composite of protein |
| 07/07/2005 | WO2005061700A1 Interstitial collagenase molecular motor |
| 07/07/2005 | WO2005061698A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | WO2005061548A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | WO2005061539A2 Treatment of viral infections |
| 07/07/2005 | WO2005061537A2 Squamous cell carcinoma antigens and use thereof |
| 07/07/2005 | WO2005061536A1 Secreted neural apoptosis inhibiting proteins |
| 07/07/2005 | WO2005061535A1 Novel antimicrobial peptides with heparin binding activity |
| 07/07/2005 | WO2005061534A2 Improved tuberculosis vaccines |
| 07/07/2005 | WO2005061532A1 Pathogenic infection detection compositions and methods |
| 07/07/2005 | WO2005061529A1 Peptide inhibiting angiontensin converting enzyme |
| 07/07/2005 | WO2005061452A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/07/2005 | WO2005061041A1 Insulin delivery system with sensor |
| 07/07/2005 | WO2005061007A1 Method of suppressing cancer |
| 07/07/2005 | WO2005061002A2 Composition and methods for modulating cns activity |
| 07/07/2005 | WO2005060998A2 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | WO2005060997A2 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | WO2005060996A2 Method of altering the pka type i signalling pathway |
| 07/07/2005 | WO2005060993A1 Synthetic protein as tumor-specific vaccine |
| 07/07/2005 | WO2005060992A1 Therapeutic agents and uses therefor |
| 07/07/2005 | WO2005060991A1 Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues |
| 07/07/2005 | WO2005060990A2 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury |
| 07/07/2005 | WO2005060989A1 A pharmaceutical composition comprising an active principle and sulphobetaine |
| 07/07/2005 | WO2005060988A1 Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility |
| 07/07/2005 | WO2005060987A1 A composition for cartilage therapeutics and using method thereof |
| 07/07/2005 | WO2005060986A1 Glp-1 (9-36) methods and compositions |
| 07/07/2005 | WO2005060985A1 Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists |